Lung Cancer: Symptoms, CT Findings, and Precision Treatment

Lung cancer is a disease in which abnormal cells grow in the lung and may spread if not diagnosed and treated early. Modern CT imaging, biopsy techniques, molecular testing, and precision therapies now help doctors tailor care to the type and stage of each patient’s cancer.

Overview

Lung cancer begins when cells in the lungs develop genetic changes that allow them to grow and divide in an uncontrolled way. Over time, these abnormal cells may form a nodule or mass, invade nearby tissues, or spread through lymph nodes and the bloodstream to other parts of the body. Although smoking remains the strongest known risk factor, lung cancer can also occur in people who have never smoked.

Doctors generally classify lung cancer into two main groups: non-small cell lung cancer and small cell lung cancer. Non-small cell lung cancer is the more common group and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Small cell lung cancer tends to grow and spread more quickly, and it is usually treated differently from non-small cell lung cancer.

Modern lung cancer care is increasingly personalized. A patient’s treatment plan depends not only on the location and stage of the tumor, but also on the tumor’s microscopic appearance and molecular features. CT imaging, PET-CT, bronchoscopy, image-guided biopsy, pathology, and genetic or biomarker testing all help the care team select the most appropriate therapy.

Lung Cancer Symptoms

Lung cancer may not cause symptoms in its early stages. This is one reason why screening with low-dose CT is important for selected people at higher risk. When symptoms do occur, they can be similar to those caused by infections, chronic bronchitis, asthma, or other lung conditions, so medical evaluation is needed to understand the cause.

Common symptoms can include a cough that does not go away, a change in a long-standing cough, coughing up blood or rust-colored sputum, chest discomfort, wheezing, shortness of breath, hoarseness, fatigue, loss of appetite, or unexplained weight loss. Some patients have repeated episodes of pneumonia or bronchitis in the same area of the lung because a tumor is partly blocking an airway.

Lung cancer can also cause symptoms outside the chest if it spreads or affects body chemistry. These may include bone pain, headaches, weakness, swelling in the face or neck, or unexplained changes such as high calcium levels. Such symptoms do not automatically mean cancer is present, but they should be assessed promptly by a qualified doctor.

Causes and Risk Factors

Lung cancer develops when genetic damage builds up in lung cells. Tobacco smoke is the leading preventable cause because it contains many substances that can damage DNA. The risk is related to how much and how long a person has smoked, but quitting at any age lowers future risk and benefits heart and lung health.

Other risk factors can also contribute. These include secondhand smoke exposure, radon gas, asbestos, silica, diesel exhaust, air pollution, prior radiation therapy to the chest, a personal history of certain lung diseases, and a family history of lung cancer. Workplace exposures are especially important to discuss with a doctor, particularly for people who have worked in construction, mining, shipbuilding, manufacturing, or industries involving dusts and chemicals.

Some people develop lung cancer despite having no known major risk factor. This is more often seen with certain types of adenocarcinoma and may be associated with specific molecular changes, such as EGFR mutations or ALK rearrangements. Because lung cancer is biologically diverse, testing the tumor can be essential for choosing the most effective treatment approach.

CT Findings and Diagnostic Evaluation

Computed tomography, or CT, is one of the most important imaging tools for detecting and evaluating lung abnormalities. A CT scan can show small nodules that may not be visible on a standard chest X-ray. It can also help doctors assess the size, shape, density, and location of a lesion and whether nearby lymph nodes, airways, blood vessels, pleura, or chest wall appear involved.

CT findings that may raise suspicion include a growing lung nodule, a spiculated or irregular border, a solid mass, a part-solid or ground-glass nodule that persists over time, collapse of part of the lung, narrowing or blockage of an airway, enlarged lymph nodes, pleural thickening, or fluid around the lung. However, CT cannot diagnose lung cancer by itself. Infections, inflammation, scar tissue, and benign tumors can sometimes look similar, so results must be interpreted in context.

When cancer is suspected, further evaluation may include PET-CT to look for metabolically active disease, brain MRI in selected cases, bronchoscopy, endobronchial ultrasound, CT-guided needle biopsy, or surgical biopsy. The tissue sample is examined by a pathologist to confirm the diagnosis and determine the cancer subtype.

For many patients with non-small cell lung cancer, additional biomarker testing is recommended. This may include testing for EGFR, ALK, ROS1, BRAF, MET, RET, NTRK, KRAS, and other alterations, as well as PD-L1 expression. These results can identify whether targeted therapies or immunotherapy are likely to be useful.

Staging and Treatment Planning

Staging describes how far the cancer has spread and is central to treatment planning. In non-small cell lung cancer, stages range from early, localized disease to cancer that has spread to lymph nodes or distant organs. Small cell lung cancer is often described as limited stage or extensive stage, although more detailed staging may also be used.

A staging evaluation may involve CT scans of the chest and abdomen, PET-CT, brain MRI, lymph node sampling, and blood tests. The goal is to define whether the tumor can be removed surgically, whether lymph nodes are involved, and whether there is spread to bones, brain, liver, adrenal glands, or other sites. Accurate staging helps avoid both undertreatment and unnecessary treatment.

Treatment decisions are usually made by a multidisciplinary team, which may include medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, radiologists, pathologists, nuclear medicine specialists, oncology nurses, and rehabilitation or supportive care professionals. The team considers tumor stage, tumor biology, lung function, heart health, other medical conditions, patient preferences, and expected benefits and risks.

Precision Treatment Options

For early-stage non-small cell lung cancer, surgery may offer the best chance of long-term disease control when the tumor can be safely removed. Operations may include removal of a segment, lobe, or, less commonly, an entire lung. Some patients may receive chemotherapy, immunotherapy, targeted therapy, or radiation before or after surgery, depending on stage and biomarker results.

Radiation therapy uses carefully planned beams of energy to treat cancer while limiting dose to nearby healthy tissue. Stereotactic body radiation therapy may be used for selected small tumors, especially when surgery is not suitable. Radiation can also be combined with chemotherapy for some locally advanced cancers or used to relieve symptoms caused by tumor pressure or spread.

Systemic treatments travel through the body and are important when cancer has spread or when there is a risk that microscopic disease remains. Options include chemotherapy, immunotherapy, targeted therapy, or combinations. Targeted therapies are designed for tumors with specific driver changes such as EGFR mutations or ALK, ROS1, RET, MET, BRAF, or NTRK alterations. Immunotherapy helps the immune system recognize and attack cancer cells and may be guided by PD-L1 testing and other clinical factors.

Small cell lung cancer is commonly treated with chemotherapy and immunotherapy, and radiation therapy may be added depending on stage and response. Because every case is different, patients should ask their oncology team which goal applies to their treatment: cure, long-term control, reducing the chance of recurrence, symptom relief, or improving quality of life.

Prevention, Self-Care, and When to See a Doctor

The most important step to reduce lung cancer risk is to avoid tobacco smoke. People who smoke should be supported with evidence-based quitting strategies, which may include counseling, nicotine replacement, and prescription medicines when appropriate. Avoiding secondhand smoke, testing homes for radon where relevant, using workplace protective equipment, and following occupational safety guidance can also reduce exposure risks.

Low-dose CT screening may be recommended for some adults with a significant smoking history who are within a specific age range and currently smoke or quit within a defined period. Screening criteria vary by country and guideline, so patients should discuss their personal eligibility with a healthcare professional. Screening is intended to detect cancer earlier, but it can also find benign nodules, so follow-up plans are important.

During and after treatment, self-care focuses on maintaining strength, nutrition, breathing capacity, and emotional well-being. Patients may benefit from pulmonary rehabilitation, light activity as tolerated, vaccination guidance, symptom management, smoking cessation support, nutrition counseling, and psychosocial care. Any new or worsening symptoms should be communicated to the care team rather than managed alone.

A doctor should be consulted for a persistent cough, coughing blood, unexplained chest pain, shortness of breath, recurring lung infections, unexplained weight loss, or abnormal imaging results. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat lung cancer for international patients, including imaging, pathology, staging, surgery, radiation, and systemic therapies when appropriate.

Frequently asked questions

Can lung cancer be found before symptoms appear?

Yes. Some lung cancers are found through low-dose CT screening in people at higher risk, often before symptoms develop. Screening is not recommended for everyone, so eligibility should be discussed with a doctor based on age, smoking history, and overall health.

Does an abnormal CT scan always mean lung cancer?

No. CT scans can show nodules or spots caused by infections, inflammation, old scars, or benign growths. Doctors assess the size, shape, growth pattern, and risk factors, and they may recommend follow-up imaging, PET-CT, or biopsy when needed.

What is the difference between a lung nodule and a lung mass?

A lung nodule is generally a small rounded area seen on imaging, while a mass is larger and may be more concerning. Size alone does not confirm cancer, but larger or growing lesions usually require more detailed evaluation.

Why is biomarker testing important in lung cancer?

Biomarker testing looks for specific changes in the tumor that may guide treatment. In some non-small cell lung cancers, results can identify targeted therapies or help determine whether immunotherapy is likely to be beneficial.

Is surgery always needed for lung cancer?

No. Surgery is often considered for early-stage non-small cell lung cancer when the tumor can be removed safely. Other patients may be treated with radiation therapy, chemotherapy, immunotherapy, targeted therapy, or combinations depending on the stage and cancer type.

Can people who never smoked get lung cancer?

Yes. Although smoking is the strongest risk factor, lung cancer can occur in people who have never smoked. Possible contributors include radon, secondhand smoke, air pollution, occupational exposures, family history, and tumor-specific genetic changes.

References

• World Health Organization
• National Cancer Institute
• American Cancer Society
• European Society for Medical Oncology
• National Comprehensive Cancer Network

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.